Alamar Biosciences, Inc. (ALMR) company profile
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)
Close on Nov 17, 2026Market cap $2.13BP/E –Yield –
About Alamar Biosciences
Laboratory Analytical Instruments, SIC 3826
Alamar Biosciences, Inc. is listed on Nasdaq under the ticker ALMR, in the SEC industry Laboratory Analytical Instruments. It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2025.
Company profile
Company
- Legal name
- Alamar Biosciences, Inc.
- Headquarters
- Fremont, CA
- Address
- 47071 Bayside Parkway 94538
- Phone
- (510) 626-9888
- Website
- alamarbio.com
- Industry
- Laboratory Analytical Instruments
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- ALMR
- Exchange
- Nasdaq
- IPO date
- Apr 17, 2026
- Shares outstanding
- 69M, Jul 31, 2026
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 2104204
- CUSIP
- 010911105
- ISIN
- US0109111056
- FIGI
- BBG012FD22W7
- Share class FIGI
- BBG012FD22X6
- EIN
- 36-4899036
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Yuling Luo | Chief Executive Officer, Director | 5,888,675 |
| Shiping Chen | Chief Operating Officer, Director | 1,445,770 |
| John L. Brottem | General Counsel | 29,000 |
| Timothy Ogden White | President | 491,803 |
| Justin J. McAnear | Chief Financial Officer | 37,220 |
| Robert P. Ragusa | Director | 5,686 |
| Rebecca Chambers | Director | – |
| Frank Witney | Director | – |
| Ian W. Ratcliffe | Director | – |
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Apr 17, 2026
- Offer price
- $17.00
- Securities offered
- 11,250,000
- Gross proceeds
- $191.25M
- Exchange
- Nasdaq
- First trading day
- Apr 17, 2026
- First-day close
- $22.00+29.4%
- Lock-up ends (est.)
- Oct 14, 2026
“The initial public offering price is $17.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Apr 17, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Apr 15, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?